Published in Clin Exp Rheumatol on March 25, 2005
Recurrent pneumothorax associated with pulmonary nodules after leflunomide therapy in rheumatoid arthritis: a case report and review of the literature. Rheumatol Int (2009) 0.89
Treatment of Crohn's disease with leflunomide as second-line immunosuppression : a phase 1 open-label trial on efficacy, tolerability and safety. Dig Dis Sci (2007) 0.78
Reappraisal of the clinical use of leflunomide in rheumatoid arthritis and psoriatic arthritis. Open Access Rheumatol (2010) 0.75
Effectiveness and safety of leflunomide in the clinical practice. A different experience. Clin Exp Rheumatol (2007) 0.75
Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. N Engl J Med (1996) 11.76
Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres. BMJ (2000) 2.49
[Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France]. Therapie (1985) 2.41
Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies. Acta Psychiatr Scand (2009) 2.07
Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment. Br J Rheumatol (1998) 2.02
Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non-case study in the French pharmacovigilance system database. Br J Clin Pharmacol (1997) 2.02
Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability. Eur J Clin Pharmacol (2000) 2.01
Benzodiazepines and hip fractures in elderly people: case-control study. BMJ (2001) 1.85
Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev (2006) 1.82
Under-reporting of adverse drug reactions in general practice. Br J Clin Pharmacol (1997) 1.78
Under-reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel system. Eur J Clin Pharmacol (1998) 1.78
Mutations in the gyrA, parC, and parE genes associated with fluoroquinolone resistance in clinical isolates of Mycoplasma hominis. Antimicrob Agents Chemother (1999) 1.75
Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis. Clin Pharmacokinet (1996) 1.75
[Iatrogenic medication: estimation of its prevalence in French public hospitals. Regional Centers of Pharmacovigilance]. Therapie (1999) 1.72
Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (1999) 1.62
Spontaneous reporting: how many cases are required to trigger a warning? Br J Clin Pharmacol (1991) 1.55
Role of anti-tumour necrosis factor-alpha therapeutic agents in the emergence of infections. Clin Microbiol Infect (2006) 1.52
Accuracy of self-report and toxicological assays to detect substance misuse disorders in parasuicide patients. Acta Psychiatr Scand (2003) 1.48
Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry. Arthritis Rheum (2010) 1.47
NSAIDs, misoprostol, and gastrointestinal bleeding. Lancet (1991) 1.40
Manual or computer-based literature searches: is one best for pharmacovigilance? DICP (1991) 1.38
Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry. Ann Rheum Dis (2009) 1.30
Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry. Arthritis Care Res (Hoboken) (2010) 1.25
Incidence and risk of fatal myocardial infarction and stroke events in rheumatoid arthritis patients. A systematic review of the literature. Clin Exp Rheumatol (2008) 1.22
Mapping of the prostate in endorectal coil-based MRI/MRSI and CT: a deformable registration and validation study. Med Phys (2004) 1.21
Benzodiazepine use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use. Eur J Clin Pharmacol (2001) 1.19
Cytokine imbalance with increased production of interferon-alpha in psoriasiform eruptions associated with antitumour necrosis factor-alpha treatments. Br J Dermatol (2009) 1.19
False-positives in spontaneous reporting: should we worry about them? Br J Clin Pharmacol (1994) 1.17
Influence of porosity on the mechanical resistance of hydroxyapatite ceramics under compressive stress. Biomaterials (1995) 1.17
Power and weakness of spontaneous reporting: a probabilistic approach. J Clin Epidemiol (1992) 1.17
Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the 'Orencia and Rheumatoid Arthritis' registry. Ann Rheum Dis (2012) 1.16
Mycoplasmas and arthritides. Rev Rhum Engl Ed (1997) 1.15
Remitting seronegative symmetrical synovitis with pitting oedema: disease or syndrome? Ann Rheum Dis (1995) 1.11
Comparing the toxicity of two drugs in the framework of spontaneous reporting: a confidence interval approach. J Clin Epidemiol (1996) 1.11
Propionibacterium acnes isolated from synovial tissue and fluid in a patient with oligoarthritis associated with acne and pustulosis. Arthritis Rheum (1998) 1.09
Nonsteroidal antiinflammatory drug use and cognitive function in the elderly: inconclusive results from a population-based cohort study. J Clin Epidemiol (1996) 1.08
Neuropathy resembling CIDP in patients receiving tumor necrosis factor-alpha blockers. Neurology (2005) 1.07
Sample size calculations for single group post-marketing cohort studies. J Clin Epidemiol (1994) 1.06
Epicondylitis after treatment with fluoroquinolone antibiotics. J Bone Joint Surg Br (1995) 1.03
In-vitro activity of grepafloxacin, a new fluoroquinolone, against mycoplasmas. J Antimicrob Chemother (1999) 1.02
Mycoplasmas in rheumatoid arthritis and other human arthritides. J Clin Pathol (1996) 1.02
Pelvic floor maximal strength using vaginal digital assessment compared to dynamometric measurements. Neurourol Urodyn (2004) 1.00
Comparison of 500 spontaneous and 500 published reports of adverse drug reactions. Eur J Clin Pharmacol (1990) 1.00
Is reporting rate a good predictor of risks associated with drugs? Br J Clin Pharmacol (1999) 0.99
Pelvic floor muscle function in continent and stress urinary incontinent women using dynamometric measurements. Neurourol Urodyn (2004) 0.99
Mycoplasma fermentans, but not M penetrans, detected by PCR assays in synovium from patients with rheumatoid arthritis and other rheumatic disorders. J Clin Pathol (1996) 0.99
Mycoplasma fermentans in joints of patients with rheumatoid arthritis and other joint disorders. Lancet (1996) 0.98
The effect of imatinib (Glivec) on scleroderma and normal dermal fibroblasts: a preclinical study. Dermatology (2008) 0.98
Systematic detection of mycoplasmas by culture and polymerase chain reaction (PCR) procedures in 209 synovial fluid samples. Br J Rheumatol (1997) 0.97
Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trial. Br J Dermatol (2012) 0.96
Anti-nuclear antibodies, anti-DNA and C4 complement evolution in rheumatoid arthritis and ankylosing spondylitis treated with TNF-alpha blockers. Clin Exp Rheumatol (2008) 0.96
Patterns of neuroleptic drug prescription: a national cross-sectional survey of a random sample of French psychiatrists. Br J Clin Pharmacol (2000) 0.95
Isolated avulsion fracture of the lesser tubercle of the humerus in children. Acta Orthop Belg (1994) 0.95
Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study. Pharmacoepidemiol Drug Saf (2007) 0.94
Genotypic characterization of seven strains of Mycoplasma fermentans isolated from synovial fluids of patients with arthritis. J Clin Microbiol (1998) 0.92
Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3 x 400 mg/day vs placebo. Osteoarthritis Cartilage (1998) 0.92
Methotrexate in rheumatoid arthritis. An update. Drugs (1994) 0.90
The link between sunshine and phototoxicity of sparfloxacin. Br J Clin Pharmacol (2000) 0.89
Stereoselective disposition of ibuprofen enantiomers in human cerebrospinal fluid. Br J Clin Pharmacol (1995) 0.89
Periganglionic foraminal steroid injections performed under CT control. AJNR Am J Neuroradiol (1998) 0.89
Benzodiazepine use in patients hospitalized in a department of internal medicine: frequency and clinical correlates. Pharmacoepidemiol Drug Saf (2002) 0.88
Successful treatment of relapsing polychondritis with infliximab. Clin Exp Rheumatol (2004) 0.88
Computerized comparison of six adverse drug reaction assessment procedures. Clin Pharmacol Ther (1986) 0.88
What are the risks of third-generation oral contraceptives? Are third-generation oral contraceptives safe? Hum Reprod (1996) 0.87
Pharmacovigilance data mining with methods based on false discovery rates: a comparative simulation study. Clin Pharmacol Ther (2010) 0.87
False discovery rate estimation for frequentist pharmacovigilance signal detection methods. Biometrics (2009) 0.87
Temporal trends in spontaneous reporting of unlabelled adverse drug reactions. Br J Clin Pharmacol (1997) 0.86
Patterns of risperidone prescription: a utilization study in south-west France. Acta Psychiatr Scand (2004) 0.86
[Results of a regional survey on the treatment of rhizomelic pseudopolyarthritis and temporal arteritis. Apropos of 242 cases treated by various modalities with synthetic antimalarials, corticoids and non-steroidal anti-inflammatory agents]. Rev Rhum Mal Osteoartic (1983) 0.85
Adverse drug reactions: physicians' opinions versus a causality assessment method. Eur J Clin Pharmacol (1994) 0.85
Traumatic tear of the rotator interval. J Shoulder Elbow Surg (1997) 0.85
The CADEUS study: methods and logistics. Pharmacoepidemiol Drug Saf (2007) 0.84
Remitting seronegative symmetrical synovitis with pitting edema (RS3PE): a form of paraneoplastic polyarthritis? J Rheumatol (1999) 0.84
[Schwann cell proliferation in diabetic neuropathy. Clinical and ultrastructural study of a case]. Nouv Presse Med (1973) 0.83
[Organization and results of drug vigilance in France]. Rev Epidemiol Sante Publique (1994) 0.83
Frozen shoulder. Joint Bone Spine (2000) 0.83
Side effects of spiramycin masquerading as local anesthetic toxicity during labor epidural analgesia. Int J Obstet Anesth (2010) 0.83
Prednisolone concentrations in cerebrospinal fluid after oral prednisone. Preliminary data. Rev Rhum Engl Ed (1997) 0.82
Comparisons of approaches to pelvic floor muscle training for urinary incontinence in women: an abridged Cochrane systematic review. Eur J Phys Rehabil Med (2012) 0.82